The Canadian Partnership Against Cancer’s System Performance web application is designed to provide users with access to the latest available data and analysis measuring the quality of cancer control across Canada. Learn more about how this tool can help support your work.
Learn more about how our cancer system is performing
Breast Cancer Screening Outside Recommended Guidelines
Percentage of all self-reported screening† mammograms performed within and outside of guideline-recommended age groups (50 to 74 years), by province/territory - 2012 reporting year
* Suppressed due to small numbers. † A woman is deemed eligible for screening mammography if her reason for undergoing a mammogram is not to investigate previously detected lumps or breast problems, or as follow-up to breast cancer treatment. E Interpret with caution owing to large variability in the estimate. ‡ Number of cases in the Canadian Community Health Survey population. Sample weights were used to get estimates representative of the full Canadian population (See data table). Outside Guidelines (all other ages): includes all women who responded to this question between age 35-49 and 75+. Women under age 35 were not captured. Women who reported a screening mammogram in the last two years were included as screened. Data source: Statistics Canada, Canadian Community Health Survey.
Five-year relative survival ratios for breast cancer, both sexes combined, Canada,† age-standardized†† - 1992-1994 combined vs. 2006-2008 combined
† Canada data excluded QC due to difference in methodology for determining date of diagnosis. †† Age-standardized to population diagnosed with breast cancer in Canada between 1992 and 2001. "-" Data not available. Data based on 15 to 99 years of age at diagnosis. Data source: Canadian Cancer Society, Canadian Cancer Statistics.
Post-Operative Chemotherapy for Stage III Colon Cancer Patients
Percentage of Stage III colon cancer patients receiving chemotherapy following surgical resection, by patient age group, by sex – patients diagnosed in 2010
Data include AB, MB, NL, PE and SK. Data include chemotherapy started within 120 days following surgery. Data source: Provincial cancer agencies
Distribution of cases by stage at diagnosis for lung cancer – in 2010 and 2011 combined
Stage 0 includes in situ. NOS = stage not otherwise specified. In occult stage, malignant cells are present in bronchopulmonary secretions, but no tumour is seen radiographically or during bronchoscopy. Data include AB, BC, MB, NB, NL, NS, PE and SK. ON reports staging but excludes Stage 0; therefore, data not included. Data source: Provincial cancer agencies